Akorn, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris (NCT03522441) | Akorn, Inc. | 2018-04-27 |
Track Akorn, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.